Whether COMT can help with menopause symptoms is not well supported by current evidence. COMT (catechol-O-methyltransferase) is involved in breaking down estrogens and catecholamines. Certain variants (e.g., rs4680) alter enzyme activity and could theoretically influence estrogen metabolism and thermoregulation, potentially affecting hot flashes or mood changes during menopause. However, the evidence is mostly mechanistic and based on small observational studies; no robust clinical data show that COMT testing directly improves menopause management. MyBody-X may offer tests for COMT variants, but results are insufficient to guide individual treatment decisions. Menopausal changes are multifactorial, and established approaches like hormone therapy or lifestyle modifications have stronger evidence. Consumers should be cautious about overblown claims from direct-to-consumer genetic tests. A clinical evaluation with a healthcare provider remains essential.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-25fb784631f10cbee0d6efd8